Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications how zoonotic disease surveillance can influence evidence based policy decisions one
… non-traditional payers and their ever-changing priorities, how do you keep up? But, given their role in your success, how do you not? We can help you navigate the pricing and reimbursement bodies … boards to address negative coverage policies in the US and disease area concerns worldwide. To get a well-rounded view …
… and you have to consider tradeoffs, you need a tool that can help you compare, prioritize and select from your … of the attributes of alternatives, and then evaluating how alternatives perform under each attribute. Image Inform … From making drug development decisions, to phase III evidence plans, to developing pricing strategies and value …
… deep experience in sophisticated modeling methods and can advise you on the best methodology given your objectives. … (individual patient, discrete-event, etc.) Infectious disease models Linear, integer, and non-linear mathematical … analysis Our Approach From design to deliverables, publications , and ongoing support, we develop and validate …
… tools to ensure your research findings and value messages can be adopted by the relevant audiences. To help … demonstrate what your new product brings to the market and how it will be positioned relative to other products. … local markets. Key sections in a GVD include: Value story Disease burden Unmet needs Value of the product (clinical, …
… claims data, electronic medical records (EMRs), disease registries, and other health data sources—can help you better understand your market and how to position your product for success. Using database … range of data partners, including: Behavioral Risk Factor Surveillance System (BRFSS) CPRD Drug Abuse Warning Network …
… More than ever, health economic information affects how patients, providers, payers , and regulators make … and consultants , led by Dr. Stephanie Earnshaw , can help you demonstrate the economic value of your … studies include: Study Type Description Burden of Illness Disease incidence and prevalence; real-world outcomes; costs …
… Real-World Evidence Expert support for your evidence-generation program … settings increases, it is critical to understand how to incorporate real-world evidence (RWE) at every stage … you with knowledgeable and relevant support and advice. We can help you understand what RWE guidelines mean for your …
… data to help you better understand drivers that could influence your product strategy. Chart reviews, separately or in combination with other data sources or surveys , can help you understand: Clinical disease characteristics Disease progression, survival, and …
… How are United States ICER'S Evidence Ratings Determined? You can read the related research here: How are United States … ratings are assigned and identify key factors which influence ICER’s rating decisions. A total of 68 evidence …
… Market Access and Evidence Generation Strategies At every stage of your product’s lifecycle, we can help you develop a strategic roadmap to effectively … payer strategy, and health economics Literature Reviews: Disease, burden of illness, treatment pathway, epidemiology …